Changodar Ramp and Margin Recovery: Can TARIL Execute?
The transformer giant faces a critical quarter as its ₹6,630 Cr record order book meets execution reality. With new capacity delayed 4-5 months and FY27 growth guidance under pressure, Q2 is about margin trajectory, not just topline.
The Setup: Order Strength vs. Execution Headwinds
TARIL enters Q2 with a record ₹6,630 crore unexecuted order book and robust recent wins (GETCO, Damodar Valley Corp, NPCIL), but the narrative is pinched between two forces. Q1 FY27 showed revenue growth at a tepid 8% YoY (₹572.34 Cr) and consolidated PAT actually fell 5% YoY to ₹64.34 Cr—a classic margin compression despite nominal growth. The culprit: a soft quarter operationally, and the drag from low utilization at existing plants as new capacity comes online. The Street initially flagged full-year guidance for 15%+ growth as achievable; Q1 suggests execution is harder than assumed.
What to Expect in Q2
~₹550–600 Cr
Flat to low-single-digit YoY growth; Q1 was ₹572.34 Cr. Seasonal demand + early Changodar ramp offset weak momentum.
~10–12%
Key metric: can Changodar ramp drive leverage, or will start-up inefficiencies weigh? Q1 consolidated PAT margin was 11.2%; watch for improvement.
~₹62–72 Cr
Range assumes 11–12% net margin on ₹550–600 Cr revenue. Upside if utilization gains traction; downside if ramp is slower than guided.
₹1,500+Cr
Management targets 30% order growth for FY27. Q1 saw ~₹2,400 Cr; Q2 likely softer, but order book coverage remains 12+ months.
A strong Q2 means revenue holding steady YoY despite seasonal headwinds, Changodar running at >50% utilization by month-end, and PAT margins stabilizing or improving QoQ—signaling execution is on track and FY27 guidance credible. A weak Q2 means revenue slips (down 5%+ YoY), new-plant ramp is slower than guided, and PAT falls below ₹62 Cr on margin compression—which would force guidance cuts and raise questions about the Street's consensus target of ₹413.
Is TARIL on Track?
Not yet clear. Q1 was a miss relative to expectations—8% revenue growth fell short of the mid-teens guidance, and profit declined despite topline growth. Management cited operational headwinds and the planned ramp delay at Changodar. The order book is phenomenal (₹6,630 Cr, up 26% YoY), and recent wins validate demand strength in power infrastructure. But the Street's confidence in FY27 guidance is shaken; multiple analysts have cut their forecasts in recent months. Q2 is the proof point: if Changodar ramps and margins stabilize, the full-year story survives. If ramp is slow and margins compress further, expect another round of cuts and downward pressure on the stock (currently 22% below ATH).
Since Last Quarter: Business Updates & Flows
1 · Major order wins (Oct 2, Aug 29, Aug 31)
GETCO (80/125 MVAR shunt reactors), Damodar Valley Corp (500/200 MVA auto-transformers), NPCIL generator transformers (Kaiga 5&6). These validate demand across segments—transmission, utilities, and nuclear. No surprise; demand is not the issue.
2 · UK subsidiary incorporation (Sep 10, Aug 27)
TARIL approved formation of Maxwell Grid Transformers (UK) Private Limited. Part of broader international expansion strategy. Monitor for export orders going forward; not material to Q2 but signals long-term ambition.
3 · Ownership: FII and DII outflow
FII holdings fell from 8.33% (Q4 FY26) to 7.80% (Q1 FY27)—50bps outflow. DII also down 24bps to 1.53%. Promoter stable at 64.36%. Suggests institutional caution; watch for further selling if Q2 disappoints.
4 · Dividend: Sep 18 record date (announced Aug 29)
FY26 dividend announced; routine. No material impact to Q2 trading or guidance.
5 · Trading window closed (Sep 28, effective Oct 1)
Closure until 48 hours post-results (Oct 15). Standard; no special activity flagged.
The Three Things to Watch on Oct 13
1 · Changodar utilization: is the ramp tracking?
Management's full-year story hinges on this plant running at 50%+ utilization by Q2-end and 70%+ by Q3. Any guidance cut on timing or expected utilization would be a red flag. Watch for deployed capacity and orders allocated to the new plant.
2 · Revenue growth trajectory: is 15%+ FY27 guidance realistic?
Q1 came in at 8% YoY. Q2 needs acceleration or FY27 guidance (which implies ~14% growth after 8% in Q1) becomes implausible. Revenue miss would force cuts; management's commentary on order conversion will be critical.
3 · Operating margin recovery: do profits catch up to revenue?
This is the real story. Q1's 5% profit decline on 8% revenue growth showed margin compression. Q2 profit should be flat or positive YoY for the narrative to work. If margins stay under pressure, consensus target of ₹413 is too high, and the stock is repricing lower.
TARIL is a name caught between a strong order book and weak execution—the record ₹6,630 crore backlog is genuine, but Q1's soft print and Changodar's delayed ramp have dented confidence. The Street's ₹413–543 consensus assumes FY27 guidance holds and margins recover in H2. Q2 is the verdict: if revenue accelerates and operating leverage shows up, the bull case survives. If margins stay compressed and growth remains in the single digits, expect downside revisions and institutional outflow to accelerate. The company has the orders and the capacity to win. Now it needs to prove it can convert them into profit.